secwatch.observer — SEC 8-K summary
======================================

Issuer:     XBiotech Inc. (XBIT)
CIK:        0001626878
Form:       8-K
Filed at:   2024-12-31T23:59:59+00:00
Accession:  0001171843-24-007128
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

XBiotech appoints renowned immunologist Dr. Tak W. Mak to its Board of Directors
--------------------------------------------------------------------------------

- Dr. Mak appointed December 24, 2024 to fill board vacancy; will serve until next annual meeting.
- Dr. Mak is a professor at University of Toronto, cloned T cell receptor (1984), and identified immune checkpoint CTLA-4.
- He co-founded Agios Pharmaceuticals, which developed multiple FDA-approved cancer treatments.
- Audit Committee remains two independent directors (McKenzie, Waldin); vacancy to be filled per Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626878/000117184324007128/0001171843-24-007128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626878/000117184324007128/f8k_123124.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-007128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer